Reported 674,105 shares, down 115,894 (14.7%) from the prior quarter.
Reported value -38.0%; share count -14.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-03-31 | 1695000 |
| 2021-06-30 | 4613000 |
| 2021-09-30 | 7833000 |
| 2021-12-31 | 9811000 |
| 2022-03-31 | 4819000 |
| 2022-06-30 | 2987000 |
| 2022-09-30 | 3475000 |
| 2022-12-31 | 2605515 |
| 2023-03-31 | 3445128 |
| 2023-06-30 | 7184315 |
| 2023-09-30 | 5858421 |
| 2023-12-31 | 3003950 |
| 2024-03-31 | 2175680 |
| 2024-06-30 | 2251376 |
| 2024-09-30 | 2395468 |
| 2024-12-31 | 2270848 |
| 2025-03-31 | 1770775 |
| 2025-06-30 | 1894290 |
| 2025-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2025 | Reduced | 0 | -1,413,649 (-100.0%) | 0 | $0 | 2025-11-07 | |
| Q2 2025 | Added | 1,413,649 | +30,231 (2.2%) | < 0.01% | $1,894,290 | 2025-08-11 | |
| Q1 2025 | Reduced | 1,383,418 | -1,246 (-0.1%) | < 0.01% | $1,770,775 | 2025-05-09 | |
| Q4 2024 | Unchanged | 1,384,664 | 0 (0.0%) | < 0.01% | $2,270,848 | 2025-02-11 | |
| Q3 2024 | Added | 1,384,664 | +20,194 (1.5%) | < 0.01% | $2,395,468 | 2024-11-13 | |
| Q2 2024 | Reduced | 1,364,470 | -167,699 (-10.9%) | < 0.01% | $2,251,376 | 2024-08-13 | |
| Q1 2024 | Added | 1,532,169 | +7,321 (0.5%) | < 0.01% | $2,175,680 | 2024-05-10 | |
| Q4 2023 | Added | 1,524,848 | +171,864 (12.7%) | < 0.01% | $3,003,950 | 2024-02-14 | |
| Q3 2023 | Added | 1,352,984 | +257,814 (23.5%) | < 0.01% | $5,858,421 | 2023-11-14 | |
| Q2 2023 | Added | 1,095,170 | +96,582 (9.7%) | < 0.01% | $7,184,315 | 2023-08-14 | |
| Q1 2023 | Added | 998,588 | +19,071 (1.9%) | < 0.01% | $3,445,128 | 2023-05-15 | |
| Q4 2022 | Added | 979,517 | +514 (0.1%) | < 0.01% | $2,605,515 | 2023-02-10 | |
| Q3 2022 | Added | 979,003 | +304,898 (45.2%) | < 0.01% | $3,475,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 674,105 | -115,894 (-14.7%) | < 0.01% | $2,987,000 | 2022-08-12 | |
| Q1 2022 | Added | 789,999 | +7,605 (1.0%) | < 0.01% | $4,819,000 | 2022-05-13 | |
| Q4 2021 | Added | 782,394 | +161,708 (26.1%) | < 0.01% | $9,811,000 | 2022-02-14 | |
| Q3 2021 | Added | 620,686 | +292,074 (88.9%) | < 0.01% | $7,833,000 | 2021-11-12 | |
| Q2 2021 | Added | 328,612 | +268,612 (447.7%) | < 0.01% | $4,613,000 | 2021-08-13 | |
| Q1 2021 | New | 60,000 | +60,000 (0.0%) | < 0.01% | $1,695,000 | 2021-05-14 |
Who else reported the position
61 managers reported IKENA ONCOLOGY INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | Unchanged | 5,018,178 | 0 | 3.72% | $22,231,000 | 3 qtrs |
| FMR LLC | Reduced | 4,395,719 | -268,742 | < 0.01% | $19,473,000 | 6 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 2,933,941 | 0 | 0.24% | $12,997,000 | 6 qtrs |
| BVF INC IL | Added | 2,503,071 | +1,500 | 0.54% | $11,089,000 | 6 qtrs |
| Omega Fund Management LLC | Unchanged | 2,249,123 | 0 | 3.18% | $9,964,000 | 6 qtrs |
| CITADEL ADVISORS LLC | Reduced | 2,126,401 | -896 | < 0.01% | $9,420,000 | 6 qtrs |
| Artal Group S A | Unchanged | 1,549,513 | 0 | 0.37% | $6,864,000 | 6 qtrs |
| CHI Advisors LLC | Added | 1,090,937 | +276,182 | 1.85% | $4,833,000 | 6 qtrs |
| Verition Fund Management LLC | New | 1,021,890 | +1,021,890 | 0.09% | $4,527,000 | 1 qtr |
| Point72 Asset Management L P | Added | 688,696 | +340,000 | 0.01% | $3,051,000 | 2 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 12, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 674,105
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.